Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Personality-influencing gene may be a key to long life

By R&D Editors | January 9, 2013

The human genome is like a roadmap for the body, but our understanding of the road signs that point some people toward a long life and others to an early death is still limited. Now, research from the U.S. Department of Energy (DOE)’s Brookhaven National Laboratory and the University of California, Irvine finds that genes involved in regulating personality may also be keys to longevity. Study results appear online in the Journal of Neuroscience.

“There’s a lot of public interest in health and longevity, but we really don’t have a good handle on the mechanism of why certain individuals may live longer while others don’t—and how this relates to certain genetic variants and lifestyles,” says Panayotis Thanos, a neuroscientist in the Behavioral Pharmacology and Neuroimaging Lab at Brookhaven Lab. Thanos led the research along with Robert Moyzis at UC Irvine, and Nora Volkow, a psychiatrist who conducts research at Brookhaven Lab and is also the Director of the National Institute on Drug Abuse.

“We obviously expect genetic variants to play a role, so we looked at the effect of the interaction of specific genetic variants associated with active personality traits on longevity,” Thanos says.

Thanos and his team studied a personality-modifying dopamine gene in a group of 1,151 individuals between 90 and 109 years old. This genetic variant—a derivative of a dopamine-receptor gene (the DRD4 7R allele)—appears at significantly higher rates in individuals over the age of 90, and is linked to lifespan increases in mice. The participants were part of the Leisure World Cohort Study, established in 1981 as a health survey among residents of the Leisure World retirement community in Laguna Woods, Calif.

Beginning in 2003, 233 surviving participants over 90 years old from the Leisure World cohort were surveyed and genotyped at the human dopamine receptor D4 (DRD4) gene and compared to a European ancestry-matched control population.

The DRD4 gene is known to regulate traits such as motivation and thrill seeking, and is also associated with attention deficit hyperactivity disorder (ADHD) and addictive and risky behavior. More than 90% of people have a DRD4 gene with groups of alleles repeated 2, 4, or 7 times, and that variation could be the difference that enables a person to live past the age of 90.

This “oldest-old” population had a 66% increase in individuals carrying the 7R allele relative to the younger control group (aged 7 to 45), and the presence of the 7R allele was strongly correlated with increased levels of physical activity. Thanos’ team also found that the DRD4 gene plays a role in protecting against dementia.

“We found an association between exercise and protection from dementia, but only for DRD4 7R subjects,” he says. High levels of activity were correlated with much lower-than-expected prevalence of dementia, while low activity rates were correlated with far higher prevalence than expected. “This suggests that individuals with the DRD4 7R variant may be more sensitive to both the beneficial effects of activity as well as the detrimental consequences of inactivity,” Thanos says.

These findings were further supported in laboratory experiments on DRD4-knockout mice, which do not have the DRD4 gene. Thanos and his team compared environmental effects on the lifespan of these mice to those of mice with DRD4 genes. Two types of housing environments were used—a standard laboratory environment, and an enriched environment that included social interaction with multiple options for physical activity and exploration.

In line with the findings in the human population, mice without the DRD4 gene had a 7 to 9.7% shorter lifespan than mice with the gene. They also found that mice in enriched environments lived 5.7% longer than mice in deprived environments, but only if the DRD4 gene was present.

“The human and animal data support each other, they match up so beautifully,” Thanos says. “This is a very interesting gene-environment interaction. We know that lifestyle changes can have tremendous impact on lifespan and, as we see here, the interaction of specific lifestyle changes and environment are also dependent on specific genetic variants.”

Source: Brookhaven National Laboratory

Related Articles Read More >

Parallel Bio’s embraces in-house drug development as FDA backs animal testing alternatives
R&D 100 Winner Spotlight: A closer look at Thermo Fisher Scientific’s trio of R&D 100 wins in 2025
Life sciences M&A hit $240B in 2025 as Big Pharma preps for patent cliffs
Hansoh Bio signs 32,000-sq.-ft. lab lease at Research Square in Rockville, MD
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE